The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and safety of trastuzumab (T-mab) and paclitaxel for T-mab naïve patients with HER2 positive previously treated metastatic gastric cancer (JFMC45-1102).
Akira Miki
No relevant relationships to disclose
Kazuhiro Nishikawa
No relevant relationships to disclose
Hirokazu Noshiro
No relevant relationships to disclose
Akira Tsuburaya
No relevant relationships to disclose
Yasunori Nishida
No relevant relationships to disclose
Yasuhide Yamada
No relevant relationships to disclose
Hiroto Miwa
No relevant relationships to disclose
Yoshinori Sakai
No relevant relationships to disclose
Kazuhiro Yoshida
No relevant relationships to disclose
Yasuhiro Kodera
No relevant relationships to disclose
Narikazu Boku
No relevant relationships to disclose
Satoshi Morita
No relevant relationships to disclose
Junichi Sakamoto
No relevant relationships to disclose
Shigetoyo Saji
No relevant relationships to disclose
Yuko Kitagawa
No relevant relationships to disclose